Indirect comparisons: a novel approach to assessing the effect of anti-HIV drugs
- PMID: 14751897
- PMCID: PMC324450
- DOI: 10.1136/bmj.328.7434.253
Indirect comparisons: a novel approach to assessing the effect of anti-HIV drugs
Comment on
-
Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials.BMJ. 2004 Jan 31;328(7434):249. doi: 10.1136/bmj.37995.435787.A6. Epub 2004 Jan 23. BMJ. 2004. PMID: 14742351 Free PMC article.
References
-
- Kirk O, Pedersen C, Law M, Gulick RM, Moyle G, Montaner J, et al. Analysis of virological efficacy in trials of anti-HIV regimens: drawbacks of not including viral load measurements after premature discontinuation of therapy. Antivir Ther 2002;7: 271-81. - PubMed
-
- Van Leeuwen R, Katlama C, Murphy RL, Squires K, Gatell J, Horban A, et al. A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients. AIDS 2003;17: 987-99. - PubMed
-
- Staszewski S, Morales-Ramirez J, Tashima KT, Rachlis A, Skiest D, Stanford J, et al. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N Engl J Med 1999;341: 1865-73. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical